Loomis Sayles & CO L P Staar Surgical CO Transaction History

Loomis Sayles & CO L P

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$51.25 - $79.34 $142,936 - $221,279	2,789 Added 0.84%	335,738 $21.5 Million
Q4 2022 Feb 10, 2023	SELL	$46.82 - $76.2 $372,780 - $606,704	-7,962 Reduced 2.34%	332,949 $16.2 Million
Q3 2022 Nov 14, 2022	SELL	$70.55 - $111.58 $290,454 - $459,374	-4,117 Reduced 1.19%	340,911 $24.1 Million
Q2 2022 Aug 05, 2022	SELL	$50.24 - $80.48 $87,970 - $140,920	-1,751 Reduced 0.5%	345,028 $24.5 Million
Q1 2022 May 13, 2022	SELL	$57.98 - $93.5 $383,421 - $618,315	-6,613 Reduced 1.87%	346,779 $27.7 Million
Q4 2021 Feb 14, 2022	SELL	$88.02 - $127.79 $819,290 - $1.19 Million	-9,308 Reduced 2.57%	353,392 $32.3 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $162.68 $670,583 - $888,720	-5,463 Reduced 1.48%	362,700 $46.6 Million
Q2 2021 Aug 13, 2021	SELL	$105.76 - $154.96 $16.7 Million - $24.5 Million	-157,995 Reduced 30.03%	368,163 $56.1 Million
Q1 2021 May 17, 2021	SELL	$78.5 - $126.48 $7.82 Million - $12.6 Million	-99,649 Reduced 15.92%	526,158 $55.5 Million
Q4 2020 Feb 12, 2021	SELL	$55.93 - $82.78 $203,976 - $301,898	-3,647 Reduced 0.58%	625,807 $49.6 Million
Q3 2020 Nov 12, 2020	BUY	$45.65 - $61.81 $544,650 - $737,455	11,931 Added 1.93%	629,454 $35.6 Million
Q2 2020 Aug 14, 2020	BUY	$29.15 - $61.54 $2.51 Million - $5.31 Million	86,233 Added 16.23%	617,523 $38 Million
Q1 2020 May 15, 2020	BUY	$25.01 - $42.4 $2.15 Million - $3.65 Million	86,089 Added 19.34%	531,290 $17.1 Million
Q4 2019 Feb 14, 2020	BUY	$24.55 - $38.13 $10.9 Million - $17 Million	445,201 New	445,201 $15.7 Million

251

47.3M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.11B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.